STAT3 and bacterial infectious disease: As the two inhibitors with their proposed effects on SMAD1/5/9 signaling showed neither an inhibitor effect nor altered STAT3 phosphorylation, other hepcidin inducing pathways may play a dominant role during bacterial infection (Girelli et al., 2016; Nairz and Weiss, 2020).